Variant report
Variant | nsv598463 |
---|---|
Chromosome Location | chr5:68887862-68911161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:84)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:1)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:68897794-68898185 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr5:68897780-68898118 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr5:68897862-68898148 | GM12878 | blood: | n/a | n/a |
4 | BCL11A | chr5:68897742-68898263 | GM12878 | blood: | n/a | n/a |
5 | CTCF | chr5:68890705-68890753 | Medullo | brain: | n/a | n/a |
6 | CTCF | chr5:68890437-68890536 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr5:68908378-68908428 | Lung_OC | lung: | n/a | n/a |
8 | EBF1 | chr5:68904882-68905202 | GM12878 | blood: | n/a | n/a |
9 | EBF1 | chr5:68897874-68898259 | GM12878 | blood: | n/a | n/a |
10 | ESR1 | chr5:68899849-68900262 | T-47D | breast: | n/a | n/a |
11 | ESR1 | chr5:68899863-68900234 | T-47D | breast: | n/a | n/a |
12 | FOSL2 | chr5:68910668-68911104 | HepG2 | liver: | n/a | n/a |
13 | FOXA1 | chr5:68899908-68900311 | HepG2 | liver: | n/a | n/a |
14 | FOXA1 | chr5:68890145-68890685 | HepG2 | liver: | n/a | n/a |
15 | GATA2 | chr5:68890239-68890673 | K562 | blood: | n/a | n/a |
16 | IRF4 | chr5:68897648-68898539 | GM12878 | blood: | n/a | n/a |
17 | IRF4 | chr5:68897692-68898345 | GM12878 | blood: | n/a | n/a |
18 | IRF4 | chr5:68904825-68905228 | GM12878 | blood: | n/a | n/a |
19 | NFIC | chr5:68897705-68898242 | GM12878 | blood: | n/a | n/a |
20 | PAX5 | chr5:68897894-68898171 | GM12878 | blood: | n/a | chr5:68897992-68898001 |
21 | PAX5 | chr5:68893616-68894118 | GM12878 | blood: | n/a | n/a |
22 | PAX5 | chr5:68904902-68905274 | GM12878 | blood: | n/a | n/a |
23 | PAX5 | chr5:68893841-68894044 | GM12878 | blood: | n/a | n/a |
24 | PAX5 | chr5:68897903-68898085 | GM12878 | blood: | n/a | chr5:68897992-68898001 |
25 | PAX5 | chr5:68893698-68894079 | GM12878 | blood: | n/a | n/a |
26 | PAX5 | chr5:68897664-68898374 | GM12878 | blood: | n/a | chr5:68897992-68898001 |
27 | PAX5 | chr5:68893776-68894058 | GM12878 | blood: | n/a | n/a |
28 | PAX5 | chr5:68897852-68898166 | GM12878 | blood: | n/a | chr5:68897992-68898001 |
29 | POLR2A | chr5:68891700-68893164 | GM12892 | blood: | n/a | n/a |
30 | POLR2A | chr5:68891742-68892643 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr5:68892676-68893105 | GM12891 | blood: | n/a | n/a |
32 | POLR2A | chr5:68891791-68892232 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | POLR2A | chr5:68892313-68892719 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr5:68897545-68898259 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr5:68898789-68899106 | GM12878 | blood: | n/a | n/a |
36 | POLR2A | chr5:68894404-68894609 | GM12878 | blood: | n/a | n/a |
37 | POLR2A | chr5:68891787-68893166 | GM12892 | blood: | n/a | n/a |
38 | POLR2A | chr5:68891742-68893147 | GM12892 | blood: | n/a | n/a |
39 | POLR2A | chr5:68892679-68893165 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr5:68897616-68898096 | GM12878 | blood: | n/a | n/a |
41 | POLR2A | chr5:68890206-68890580 | H1-hESC | embryonic stem cell: | n/a | n/a |
42 | POLR2A | chr5:68891914-68892609 | GM12891 | blood: | n/a | n/a |
43 | POLR2A | chr5:68892839-68893136 | GM12878 | blood: | n/a | n/a |
44 | POLR2A | chr5:68891828-68893113 | H1-hESC | embryonic stem cell: | n/a | n/a |
45 | POLR2A | chr5:68892817-68893077 | GM12878 | blood: | n/a | n/a |
46 | POLR2A | chr5:68892713-68893156 | GM12891 | blood: | n/a | n/a |
47 | POLR2A | chr5:68899921-68900256 | GM12878 | blood: | n/a | n/a |
48 | POLR2A | chr5:68891756-68892660 | GM12892 | blood: | n/a | n/a |
49 | POLR2A | chr5:68897581-68898436 | GM12892 | blood: | n/a | n/a |
50 | POLR2A | chr5:68891834-68892002 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GTF2H2C-1 | chr5:68889300-68889532 | NONHSAT101931 |
2 | lnc-GTF2H2C-1 | chr5:68890071-68890550 | NONHSAT101931 |
No data |
(count:1 , 50 per page) page:
1
No. | miRNA target gene | miRNA name | Chromosome Location | mirBase accession |
---|---|---|---|---|
1 | GTF2H2D | hsa-miR-30a-5p | chr5:68888221-68888242 |
Variant related genes | Relation type |
---|---|
GTF2H2C | TF binding region |
ENSG00000248477 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369193750 | chr5:68890095-68890096 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs367939611 | chr5:68890263-68890264 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs376785524 | chr5:68890264-68890265 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549792536 | chr5:68890266-68890267 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs154415 | chr5:68892137-68892138 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368078879 | chr5:68892251-68892252 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2856277 | chr5:68896890-68896891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572977107 | chr5:68897381-68897382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540403636 | chr5:68897961-68897962 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs376947395 | chr5:68897977-68897978 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs564857072 | chr5:68898005-68898006 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs375325174 | chr5:68898095-68898096 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs577007168 | chr5:68898337-68898338 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs200541864 | chr5:68898433-68898434 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs201296716 | chr5:68898568-68898569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544262222 | chr5:68898757-68898758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562475771 | chr5:68898759-68898760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529666443 | chr5:68898792-68898793 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs548919357 | chr5:68898806-68898807 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs560802257 | chr5:68898856-68898857 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs527915475 | chr5:68898857-68898858 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs552717867 | chr5:68898870-68898871 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs371577427 | chr5:68898894-68898895 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs537940316 | chr5:68899383-68899384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549825182 | chr5:68899385-68899386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111664893 | chr5:68900791-68900792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs207720 | chr5:68901444-68901445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568120518 | chr5:68901714-68901715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200744002 | chr5:68901775-68901776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs202070072 | chr5:68901890-68901891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535431777 | chr5:68901971-68901972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554586039 | chr5:68901981-68901982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573068962 | chr5:68902005-68902006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533792883 | chr5:68902009-68902010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558704601 | chr5:68902010-68902011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs58438250 | chr5:68902080-68902081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577069281 | chr5:68902513-68902514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544327277 | chr5:68902570-68902571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368053335 | chr5:68902671-68902672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189471348 | chr5:68902829-68902830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562541023 | chr5:68902860-68902861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574499409 | chr5:68902880-68902881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541792489 | chr5:68902885-68902886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560651596 | chr5:68902906-68902907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527985161 | chr5:68902953-68902954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552537113 | chr5:68902954-68902955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200966956 | chr5:68902992-68902993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201829840 | chr5:68903006-68903007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200031007 | chr5:68903013-68903014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs77124470 | chr5:68904678-68904679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 21865298 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68892000-68892200 | Active TSS | Primary neutrophils fromperipheralblood | blood |
2 | chr5:68892200-68892400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
3 | chr5:68892600-68894000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr5:68896200-68901400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
5 | chr5:68897800-68898200 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr5:68897800-68899000 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr5:68898200-68902000 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr5:68899000-68901400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
9 | chr5:68901400-68902200 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr5:68901400-68903000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
11 | chr5:68902000-68902200 | Enhancers | Primary B cells from peripheral blood | blood |
12 | chr5:68902000-68902200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr5:68902200-68902600 | Weak transcription | Primary B cells from peripheral blood | blood |
14 | chr5:68902200-68903000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
15 | chr5:68902200-68906400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
16 | chr5:68902600-68903000 | Enhancers | Primary B cells from peripheral blood | blood |
17 | chr5:68902800-68903000 | Enhancers | Primary B cells from cord blood | blood |
18 | chr5:68906400-68906600 | Enhancers | Monocytes-CD14+_RO01746 | blood |